Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Clinical trial NCT00003634 · UNKNOWN

Trial details

NCT number: NCT00003634
Sponsor: AltaRex
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1998-04-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.